News Conference News THT 2024 Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients Michael O'Riordan March 07, 2024
News Daily News HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show Yael L. Maxwell January 10, 2024